Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.175 USD | +0.47% | -12.83% | -15.10% |
Apr. 04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
Apr. 04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.10% | 190M | |
-1.17% | 41.35B | |
+42.49% | 40.38B | |
+3.18% | 39.05B | |
-12.11% | 26.67B | |
+2.78% | 24.07B | |
-23.73% | 18.36B | |
-3.30% | 11.68B | |
+22.99% | 11.6B | |
+7.64% | 11.15B |
- Stock Market
- Equities
- ABOS Stock
- News Acumen Pharmaceuticals, Inc.
- Sector Update: Health Care Stocks Post Solid Gains Thursday